A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case–control pilot study
Daniele Generali(Istituti Ospitalieri di Cremona), Francesco Schettini(Breast Cancer Research Foundation), Carla Strina(Istituti Ospitalieri di Cremona), Alexandro Membrino(Istituti Ospitalieri di Cremona), Alessandra Fontana(Università Cattolica del Sacro Cuore), Aldo Caltavituro(University of Naples Federico II), Manuela Milani(Humanitas University), Sergio Del Bianco(Precision for Medicine (United States)), Andrea Castagnetti(Ospedale di Circolo di Busto Arsizio), Federica Gattazzo(Università Cattolica del Sacro Cuore), Valeria Cervoni(University of Trieste)
Cited by 0
Related Papers
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
|Cancer Research|2009|298
Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer
|Clinical Cancer Research|2006|244
Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability
|Cancer Research|2010|205
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia
|Cell Cycle|2009|197